Sort
35,931 grants matching “parkinsons”
Decision Making on Continuous Scales in Aging and Alzheimers Disease
$495,264Roger Ratcliff · Ohio State University · R01 · FY2024 · AG
Decision Making on Continuous Scales in Aging and Alzheimers Disease
$495,264Roger Ratcliff · Ohio State University · R01 · FY2021 · AG
Decision Making on Continuous Scales in Aging and Alzheimers Disease
$495,264Roger Ratcliff · Ohio State University · R01 · FY2023 · AG
Decision Making on Continuous Scales in Aging and Alzheimers Disease
$495,264Roger Ratcliff · Ohio State University · R01 · FY2022 · AG
Decision Making on Continuous Scales in Aging and Alzheimers Disease
$495,264Roger Ratcliff · Ohio State University · R01 · FY2020 · AG
Progressive resistance exercise and dystonia pathophysiology.
$495,247Aparna Wagle Shukla · University Of Florida · R01 · FY2024 · NS
Positive allosteric modulators as PET imaging ligands for mGluR4
$495,205Anna-Liisa Brownell · Massachusetts General Hospital · R01 · FY2014 · EB
Cholinergic Mechanisms in Lewy Body Dementia
$495,090Mark S Moehle · University Of Florida · R01 · FY2024 · NS
Neuroimaging and Molecular Markers of AD and Neurodegenerative Disease after Concussion
$495,020Jasmeet Pannu Hayes · Ohio State University · R01 · FY2021 · AG
High-Throughput Genomic Approaches to Identify ALS Genes
$495,019Robert H Brown · Massachusetts General Hospital · R01 · FY2008 · NS
High-Throughput Genomic Approaches to Identify ALS Genes
$495,008Robert H Brown · Massachusetts General Hospital · R01 · FY2007 · NS
Optimization of ultrasound-facilitated blood-brain barrier opening
$495,000Elisa E Konofagou · Columbia Univ New York Morningside · R01 · FY2011 · EB
Collision Cross Section Measurements Using Fourier Transform Ion Cyclotron Resonance Techniques
$495,000David V Dearden · Brigham Young University · · FY2019 · MPS
High-Throughput Genomic Approaches to Identify ALS Genes
$494,943Robert H Brown · Massachusetts General Hospital · R01 · FY2006 · NS
Biophysical Characterization of Subthalamic Local Field Potentials in Parkinson's Disease
$494,878Cameron McIntyre · Case Western Reserve University · R01 · FY2021 · NS
The iron modulatory function of prion protein and prion disorders
$494,856Neena Singh · Case Western Reserve University · R01 · FY2016 · NS
The iron modulatory function of prion protein and prion disorders
$494,856Neena Singh · Case Western Reserve University · R01 · FY2019 · NS
The MitoPark mouse--a new model for Parkinson's Disease
$494,841Barry J. Hoffer · National Institute On Drug Abuse · Z01 · FY2007 · DA
Studies on CDNF: a new class of neurotrophic proteins
$494,841Barry J. Hoffer · National Institute On Drug Abuse · Z01 · FY2007 · DA
Dynamics of Kinesins, Dyneins, and Myosins
$494,825Paul R Selvin · University Of Illinois At Urbana-Champaign · R01 · FY2010 · AR
CORE--CLININCAL
$494,789Donna L. Masterman · University Of California Los Angeles · P50 · FY2008 · AG
THE DEVELOPMENT OF NONMOTOR BIOMARKERS TO DIAGNOSE PARKINSON'S DISEASE SUBTYPES EARLY ON
$494,774Aarhus Universitet · · FY2024 · Defense Health Agency
Architecture and Function of Striatal Dopamine Signaling Machinery
$494,746Pascal Simon Kaeser · Harvard Medical School · R01 · FY2025 · NS
Synaptic Transmission in the Retina
$494,567State University New York Stony Brook · R01 · FY2004 · EY
Developmental underpinnings of substantia nigra vulnerability
$494,533Rajeshwar B Awatramani · Northwestern University At Chicago · R01 · FY2021 · NS